Unilife Corporation (UNIS) saw a big move last session, as the company's shares fell nearly 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for URS, as the stock is now down around 34.50% in the past one-month time frame.
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
UNIS currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the health care sector include Edwards Lifesciences Corp. (EW), Venaxis, Inc. (APPY) and William Demant Holding A/S (WILYY). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
UNIS currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the health care sector include Edwards Lifesciences Corp. (EW), Venaxis, Inc. (APPY) and William Demant Holding A/S (WILYY). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
VENAXIS INC (APPY): Get Free Report
EDWARDS LIFESCI (EW): Free Stock Analysis Report
UNILIFE CORP (UNIS): Free Stock Analysis Report
WILLIAM DEMANT (WILYY): Get Free Report
To read this article on Zacks.com click here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in